Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of biologically active benzimidazolone derivatives. Its boronate ester group enables efficient carbon-carbon bond formation, making it valuable in pharmaceutical research, particularly in developing kinase inhibitors and other therapeutic agents targeting inflammation, cancer, and central nervous system disorders. The oxazole moiety enhances binding affinity to certain enzyme targets, improving selectivity in drug design.